Layzer RB: Neuromuscular Manifestations of Systemic Disease. Philadelphia, Davis, 1985.
Lehmann-Horn F, Mailänder V, Heine R, George AL: Myotonia levior is a chloride channel disorder. Hum Mol Genet 4:1397, 1995.
Lehmann-Horn F, Rüdel R, Jurkat-Rott K: Nondystrophic myotonias and periodic paralyses, in Engel AG, Franzini-Armstrong C (eds): Myology, 3rd ed. New York, McGraw-Hill, 2004, pp 1257–1300.
Lehmann-Horn F, Rüdel R, Ricker K: Membrane defects in paramyotonia congenita (Eulenburg). Muscle Nerve 10:633, 1987.
Lennon VA: Immunologic mechanisms in myasthenia gravis—a model of a receptor disease, in Franklin E (ed): Clinical Immunology Update—Reviews for Physicians. New York, Elsevier/North-Holland, 1979, pp 259–289.
Lennon VA, Lindstrom JM, Seybold ME: Experimental autoimmune myasthenia gravis in rats and guinea pigs. J Exp Med 141:1365, 1975.
Lewi Z, Bar-Khayim Y: Food poisoning from barium carbonate. Lancet 2:342, 1964.
Ligouri R, Vincent A, Clover L, et al: Morvan’s syndrome: Peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124:2417, 2001.
Lipicky RJ, Bryant SH: Ion content, potassium flux, and cable properties of myotonic, human, external intercostal muscle. Trans Am Neurol Assoc 96:34, 1971.
Lundh H, Nilsson O, Rosen I: Treatment of Lambert-Eaton syndrome: 3,4-Diaminopyridine and pyridostigmine. Neurology 34:1324, 1984.
Lütschg J, Jerusalem F, Ludin HP, et al: The syndrome of “continuous muscle fiber activity.” Arch Neurol 35:198, 1978.
Mason WP, Graus F, Land B, et al: Small-cell lung cancer, paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome. Brain 120:1279, 1997.
Matthews E, Labrum R, Sweeney MG, et al: Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 72:1544, 2009.
McFadzean AJS, Yeung R: Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J 1:451, 1967.
McKeon B, Martinez-Hernandez E, Lancaster E, et al: Glycine receptor autoimmune spectrum with stiff-man syndrome phenotype. JAMA Neurol 70:44, 2013.
McQuillen MP, Cantor HE, O’Rourke JR: Myasthenic syndrome associated with antibiotics. Arch Neurol 18:402, 1968.
Meriggioli MN, Ciafaloni E, Al-Hayk KA, et al: Mycophenolate mofetil for myasthenia gravis. Neurology 61:1438, 2003.